The sandwich-type aptasensor based on gold nanoparticles/DNA/magnetic beads for detection of cancer biomarker protein AGR2

Sensors and Actuators, B: Chemical

Volumn 209, Issue , 2015, Pages 846-852

  Hu, Ye ^a   Li, Lidong ^a   Guo, Lin ^a  

^a BEIHANG UNIVERSITY   (China)

Author keywords

AGR2; Aptasensor; Gold nanoparticles; Magnetic beads

Indexed keywords

BIOMARKERS; DISEASES; FIBER OPTIC SENSORS; GOLD; MAGNETISM; METAL NANOPARTICLES; NANOPARTICLES; OPTICAL PROPERTIES; PROTEINS;

AGR2; APTASENSOR; CANCER BIOMARKERS; DETECTION LIMITS; GOLD NANOPARTICLES; MAGNETIC BEADS; PROTEIN DETECTION; SELECTIVITY AND SENSITIVITY;

NANOMAGNETICS;

EID: 84942792199     PISSN: 09254005     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.snb.2014.12.068     Document Type: Article

References (40)

1. [1] Zhang, Y., Ali, T.Z., Zhou, H., D'Souza, D.R., Lu, Y., Jaffe, J., Liu, Z.Q., Passaniti, A., Hamburger, A.W., ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer. Cancer Res. 70 (2010), 240–248.
2. [2] Salmans, M.L., Zhao, F., Andersen, B., The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res., 15, 2013, 204.
3. [3] Fritzsche, F.R., Dahl, E., Pahl, S., Burkhardt, M., Luo, J., Mayordomo, E., Gansukh, T., Dankof, A., Knuechel, R., Denkert, C., Winzer, K.-J., Dietel, M., Kristiansen, G., Prognostic relevance of AGR2 expression in breast cancer. Clin. Cancer Res. 12 (2006), 1728–1734.
4. [4] Innes, H.E., Liu, D., Barraclough, R., Davies, M., O'neill, P.A., Platt-Higgins, A., de Silva Rudland, S., Sibson, D.R., Rudland, P.S., Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients. Br. J. Cancer 94 (2006), 1057–1065.
5. [5] Bu, H., Bormann, S., Schäfer, G., Horninger, W., Massoner, P., Neeb, A., Lakshmanan, V.K., Maddalo, D., Nestl, A., Sültmann, H., The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 71 (2011), 575–587.
6. [6] Park, K., Chung, Y.J., So, H., Kim, K., Park, J., Oh, M., Jo, M., Choi, K., Lee, E.J., Choi, Y.L., AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp. Mol. Med. 43 (2011), 91–100.
7. [7] Armes, J.E., Davies, C.M., Wallace, S., Taheri, T., Perrin, L.C., Autelitano, D.J., AGR2 expression in ovarian tumours: a potential biomarker for endometrioid and mucinous differentiation. Pathology 45 (2013), 49–54.
8. [8] Wulandari, R., Menon, U., Pereira, S.P., Timms, J.F., OP0004 testing AGR2 as an early cancer biomarker. Eur. J. Cancer, 50, 2014, e2.
9. [9] Park, S.W., Zhen, G., Verhaeghe, C., Nakagami, Y., Nguyenvu, L.T., Barczak, A.J., Killeen, N., Erle, D.J., The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 6950–6955.
10. [10] Lee, S., Bang, S., Song, K., Lee, I., Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol. Rep. 16 (2006), 747–754.
11. [11] Shi, T., Gao, Y., Quek, S.I., Fillmore, T.L., Nicora, C.D., Su, D., Zhao, R., Kagan, J., Srivastava, S., Rodland, K.D., A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum. J. Proteome Res. 13 (2013), 875–882.
12. [12] Wayner, E.A., Quek, S.I., Ahmad, R., Ho, M.E., Loprieno, M.A., Zhou, Y., Ellis, W.J., True, L.D., Liu, A.Y., Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine. Prostate 72 (2012), 1023–1034.
13. [13] Wu, J., Wang, C., Li, X., Song, Y., Wang, W., Li, C., Hu, J., Zhu, Z., Li, J., Zhang, W., Identification, characterization and application of a G-quadruplex structured DNA aptamer against cancer biomarker protein anterior gradient homolog 2. PLOS ONE, 7, 2012, e46393.
14. [14] Bunka, D.H., Stockley, P.G., Aptamers come of age – at last. Nat. Rev. Microbiol. 4 (2006), 588–596.
15. [15] O'Sullivan, C.K., Aptasensors – the future of biosensing?. Anal. Bioanal. Chem. 372 (2002), 44–48.
16. [16] Geiger, A., Burgstaller, P., Von der Eltz, H., Roeder, A., Famulok, M., RNA aptamers that bind L-arginine with sub-micromolar dissociation constants and high enantioselectivity. Nucleic Acids Res. 24 (1996), 1029–1036.
17. [17] Li, L., Mu, X., Peng, Y., Chen, Z., Guo, L., Jiang, L., Signal-on architecture for electrochemical aptasensors based on multiple ion channels. Anal. Chem. 84 (2012), 10554–10559.
18. [18] Fredriksson, S., Gullberg, M., Jarvius, J., Olsson, C., Pietras, K., Gústafsdóttir, S.M., Östman, A., Landegren, U., Protein detection using proximity-dependent DNA ligation assays. Nat. Biotechnol. 20 (2002), 473–477.
19. [19] Kleinjung, F., Klussmann, S., Erdmann, V., Scheller, F., Fürste, J., Bier, F., High-affinity RNA as a recognition element in a biosensor. Anal. Chem. 70 (1998), 328–331.
20. [20] Pavlov, V., Xiao, Y., Shlyahovsky, B., Willner, I., Aptamer-functionalized Au nanoparticles for the amplified optical detection of thrombin. J. Am. Chem. Soc. 126 (2004), 11768–11769.
21. [21] Li, L., Zhao, H., Chen, Z., Mu, X., Guo, L., Aptamer biosensor for label-free impedance spectroscopy detection of thrombin based on gold nanoparticles. Sens. Actuators B: Chem. 157 (2011), 189–194.
22. [22] Stojanovic, M.N., De Prada, P., Landry, D.W., Aptamer-based folding fluorescent sensor for cocaine. J. Am. Chem. Soc. 123 (2001), 4928–4931.
23. [23] Ding, C., Zheng, Q., Wang, N., Yue, Q., An electrochemiluminescence strategy based on aptamers and nanoparticles for the detection of cancer cells. Anal. Chim. Acta 756 (2012), 73–78.
24. [24] Zhou, X., Xing, D., Zhu, D., Jia, L., Magnetic bead and nanoparticle based electrochemiluminescence amplification assay for direct and sensitive measuring of telomerase activity. Anal. Chem. 81 (2009), 255–261.
25. [25] Mirkin, C.A., Letsinger, R.L., Mucic, R.C., Storhoff, J.J., A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 382 (1996), 607–609.
26. [26] Elghanian, R., Storhoff, J.J., Mucic, R.C., Letsinger, R.L., Mirkin, C.A., Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277 (1997), 1078–1081.
27. [27] Rosi, N.L., Mirkin, C.A., Nanostructures in biodiagnostics. Chem. Rev. 105 (2005), 1547–1562.
28. [28] Huang, C.C., Huang, Y., Cao, Z., Tan, W., Chang, H.T., Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Anal. Chem. 77 (2005), 5735–5741.
29. [29] Xia, N., Deng, D., Zhang, L., Yuan, B., Jing, M., Du, J., Liu, L., Sandwich-type electrochemical biosensor for glycoproteins detection based on dual-amplification of boronic acid-gold nanoparticles and dopamine-gold nanoparticles. Biosens. Bioelectron. 43 (2013), 155–159.
30. [30] Zheng, J., Cheng, G., He, P., Fang, Y., An aptamer-based assay for thrombin via structure switch based on gold nanoparticles and magnetic nanoparticles. Talanta 80 (2010), 1868–1872.
31. [31] Huang, X., Hao, Y., Wu, H., Guo, Q., Guo, L., Wang, J., Zhong, L., Lin, T., Fu, F., Chen, G., Magnetic beads based colorimetric detection of mercuric ion. Sens. Actuators B: Chem. 191 (2014), 600–604.
32. [32] Valentini, P., Fiammengo, R., Sabella, S., Gariboldi, M., Maiorano, G., Cingolani, R., Pompa, P.P., Gold-nanoparticle-based colorimetric discrimination of cancer-related point mutations with picomolar sensitivity. ACS Nano 7 (2013), 5530–5538.
33. [33] Lai, W., Tang, D., Zhuang, J., Chen, G., Yang, H., Magnetic bead-based enzyme-chromogenic substrate system for ultrasensitive colorimetric immunoassay accompanying cascade reaction for enzymatic fomation of squaric acid-iron (III) chelate. Anal. Chem. 86 (2014), 5061–5068.
34. [34] Duan, R., Zhou, X., Xing, D., Electrochemiluminescence biobarcode method based on cysteamine – gold nanoparticle conjugates. Anal. Chem. 82 (2010), 3099–3103.
35. [35] Zhao, J., Lin, F., Yi, Y., Huang, Y., Li, H., Zhang, Y., Yao, S., Dual amplification strategy of highly sensitive thrombin amperometric aptasensor based on chitosan-Au nanocomposites. Analyst 137 (2012), 3488–3495.
36. [36] Xu, X., Georganopoulou, D.G., Hill, H.D., Mirkin, C.A., Homogeneous detection of nucleic acids based upon the light scattering properties of silver-coated nanoparticle probes. Anal. Chem. 79 (2007), 6650–6654.
37. [37] Frens, G., Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nature 241 (1973), 20–22.
38. [38] John, T., Peter, C.S., James, H., A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss. Faraday Soc. 11 (1951), 55–75.
39. [39] Grabar, K.C., Freeman, R.G., Hommer, M.B., Natan, M.J., Preparation and characterization of Au colloid monolayers. Anal. Chem. 67 (1995), 735–743.
40. [40] Jin, R., Wu, G., Li, Z., Mirkin, C.A., Schatz, G.C., What controls the melting properties of DNA-linked gold nanoparticle assemblies?. J. Am. Chem. Soc. 125 (2003), 1643–1654.